The degradation pathways of glucagon in acidic solutions

被引:47
作者
Joshi, AB
Rus, E
Kirsch, LE [1 ]
机构
[1] Univ Iowa, Coll Pharm, Div Pharmaceut, Iowa City, IA 52242 USA
[2] Univ Iowa, Mol Anal Facil, Iowa City, IA 52242 USA
关键词
degradation pathways; deamidation; glucagon; glutaminyl; hydrolysis; peptide cleavage;
D O I
10.1016/S0378-5173(00)00438-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: Glucagon is a 29 amino acid peptide hormone that exhibits degradation via both chemical and physical pathways. The objective of the studies reported herein was to identify the degradation products and scheme for glucagon hydrolysis in acidic solutions. Methods: Solutions of glucagon in 0.01 N HCl (pH 2.5) were degraded at 60 degrees C for 70 h. One isocratic and two gradient RP-HPLC methods were developed to separate the degradation products. Structure elucidation of the separated peaks was achieved using amino acid sequencing, amino acid analysis, and mass spectrometry. Degradation was carried out in the pH range 1.5-5 to check for changes in degradation scheme with pH. Authentic samples of degradation products were degraded under similar acidic conditions to confirm precursor successor relationships in the degradation scheme. Results: Sixteen major degradation products were isolated and identified. The major pathways of degradation were found to be aspartic acid cleavage at positions 9, 15, and 21 and glutaminyl deamidation at positions 3, 20, and 24. Cleavage occurred on both sides of Asp-15 but only on the C-terminal side of Asp-9 and Asp-21. Deamidation of the Asn residue at position 28 was not detected. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:115 / 125
页数:11
相关论文
共 25 条
[1]   FORMATION AND STRUCTURE OF GELS AND FIBRILS FROM GLUCAGON [J].
BEAVEN, GH ;
GRATZER, WB ;
DAVIES, HG .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1969, 11 (01) :37-&
[2]  
BROMER WW, 1983, HDB EXPT PHARM, V66, P1
[3]   THE ROLE OF INTRAMOLECULAR NUCLEOPHILIC CATALYSIS AND THE EFFECTS OF SELF-ASSOCIATION ON THE DEAMIDATION OF HUMAN INSULIN AT LOW PH [J].
DARRINGTON, RT ;
ANDERSON, BD .
PHARMACEUTICAL RESEARCH, 1994, 11 (06) :784-793
[4]  
DIAMANT B, 1983, HDB EXPT PHARM, V6, P611
[5]  
GEIGER T, 1987, J BIOL CHEM, V262, P785
[6]   A CONFORMATIONAL STUDY OF GLUCAGON [J].
GRATZER, WB ;
BEAVEN, GH ;
RATTLE, HWE ;
BRADBURY, EM .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1968, 3 (03) :276-&
[7]  
INGLIS AS, 1983, METHOD ENZYMOL, V91, P324
[8]   TERTIARY STRUCTURE IS A PRINCIPAL DETERMINANT TO PROTEIN DEAMIDATION [J].
KOSSIAKOFF, AA .
SCIENCE, 1988, 240 (4849) :191-194
[9]  
Light A., 1967, METHOD ENZYMOL, V11, P417, DOI 10.1016/S0076-6879(67)11048-3
[10]   STABILITY OF PROTEIN PHARMACEUTICALS [J].
MANNING, MC ;
PATEL, K ;
BORCHARDT, RT .
PHARMACEUTICAL RESEARCH, 1989, 6 (11) :903-918